Rafoxanide negatively modulates STAT3 and NF-κB activity and inflammation-associated colon tumorigenesis.
Pacifico T, Stolfi C, Tomassini L, Luiz-Ferreira A, Franzè E, Ortenzi A, Colantoni A, Sica GS, Sambucci M, Monteleone I, Monteleone G, Laudisi F.
Pacifico T, et al. Among authors: tomassini l.
Cancer Sci. 2024 Nov;115(11):3596-3611. doi: 10.1111/cas.16317. Epub 2024 Sep 6.
Cancer Sci. 2024.
PMID: 39239848
Free PMC article.